Weekly Digest – 10-17 Mar 2023 Weekly Digest – 10-17 Mar 2023 13 Mar 2023: Xtandi (Enzalutamide, Oral)/ mHSPC / Astellas / Pfizer: Phase 3 China ARCHES study meets primary endpoints Announced a clinical hold on its STING agonist ADC […]
Weekly Digest – 10-17 Mar 2023 Weekly Digest – 10-17 Mar 2023 13 Mar 2023: XMT-2056 (IV) / Solid Tumors / Mersana Therapeutics: Announced a clinical hold on its STING agonist ADC in Phase 1 trial Mersana Therapeutics announced a […]
Weekly Digest – 10-17 Mar 2023 Weekly Digest – 10-17 Mar 2023 March 13, 2023: Nefecon (Delayed-release Budesonide, Oral)/ IgA Nephropathy/ Calliditas: Plans to file for full approval post-Phase 3 data Calliditas believes Phase 3 confirmatory data for Nefecon for […]
Weekly Digest – 10-17 Mar 2023 Weekly Digest – 10-17 Mar 2023 Mar 10, 2023: Keytruda (Pembrolizumab, IV)/ Metastatic malignant pleural mesothelioma / Merck: Phase 2/3 IND.227/KEYNOTE-483 study met its primary endpoint Merck announced that the KEYNOTE-483 study, evaluating Keytruda […]
